ANArzoo Newar

Arzoo Newar

*This is an algorithmically generated author record based on publicly available information.

Arzoo Newar has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Formulation, Evaluation and Comparative Study of Polyherbal Shampoo with Marketed Synthetic Shampoo

    by Arzoo Newar, Dhunusmita Barman, Padmanath Pegu, Keneisenuo Zumvii, Abdul Baquee Ahmed

    Shampoo is one of the most common form of taking care of hair for cleansing, remove dirt, grease and debris from the scalp. Polyherbal shampoos were prepared using extracts of Phyllanthus embilica L, Orange peel along with Lemon juice, Reetha powder in different concentrations. Visual assessment, pH, wetting time, detergency, foaming ability, viscosity, conditioning action were evaluated for formulated Polyherbal shampoo. The pH of shampoos produced with natural extracts is closer to the skin's pH of 5.0 to 6.0. The formulated shampoo has good rheological capabilities and is nearly identical to its marketed counterparts. The deeper areas of skin can be affected by synthetic surfactants like SLS, Span 20, and Tween 80, which can harm cell membranes. In our study powdered soapnut, sometimes called Reetha is used as natural detergent, the detergency percentage of F1 formulation was found to be 23.8%, which is satisfactory. Conditioning action of F1 and F2 formulation is found to be score 2.8 and 3, which is good while comparing with marketed shampoo. The manufactured shampoos were stable, unvarying, thicker and comparable as that of commercially marketed shampoos. The formulated polyherbal shampoos have consistent organoleptic properties, favourable pH, and good cleansing, detergency, conditioning, and foaming capabilities. Keywords: Polyherbal, shampoo, detergent, hair, cosmetic, amla


  • Open Access

    Cold Atmospheric Plasma: A Noteworthy Approach in Medical Science

    by Bedanta Bhattacharjee, Rajashri Bezbaruah, Damanbhalang Rynjah, Arzoo Newar, Sindhuja Sengupta, Padmanath Pegu, Nikita Dey, Shekhar Chandra Bora, Dhunusmita Barman

    Cold atmospheric plasma (CAP) is a novel technology with boundless significance that can be used in the medical sector that offers noninvasive in-vivo applications without damaging the living tissues. CAPs can be obtained by curtailing the concentration of high-energetic electrons per phase and by freezing molecules/atoms (devoid of charge) in plasma utilizing gas circulation and atmospheric air, which includes a variety of charged and neutral reactive entities, UV rays, electric currents, and fields, etc. that have an influence on cellular material in a multitude of diverse manners. Reactive oxygen species (ROS) and reactive nitrogen species (RNS), produced by the plasma, essentially cause biological and therapeutically advantageous plasma effects. CAP plasma has several important biological functions, including the deactivation of pathogens, induction of tissue restoration and cell propagation, the annihilation of cells by triggering apoptosis, etc. Several fundamental concepts are defined, even if the precise process of the effect of plasma on biomolecules is still not properly identified. Depending on the biological synthesis of RNS and ROS in reactions to plasma emissions, the present review described several aspects of plasma therapy in neuroscience, particularly in anti-glioblastoma, neuro-differentiation, and neuroprotection and also the various applications of CAP in medical fields where it is used in the therapy of SARS-CoV-2, cancer therapy, and chronic and acute wounds. Furthermore, the proliferation in stem cells, dental medicines, dermatology, and a brief insight into CAP devices and their risk factors was highlighted.